RESPONSE BIOMEDICAL CORP 4
4 · RESPONSE BIOMEDICAL CORP · Filed Dec 5, 2013
Insider Transaction Report
Form 4
PURVIN JEFFREY L
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2013-12-03$1.30/sh+3,695$4,804→ 8,795 total - Purchase
Common Stock
2013-12-04$1.27/sh+505$641→ 9,300 total - Purchase
Common Stock
2013-11-29$1.30/sh+800$1,040→ 5,100 total
Holdings
- 12,500(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]On June 19th, 2012, the final voting results of the annual meeting of the Company's shareholders effected a consolidation of the Company's outstanding common shares such that each twenty outstanding common shares will be consolidated into one common share.
- [F2]Shares held directly by the Purvin Family Trust, a trust for the benefit of the Reporting Person and the Reporting Person's spouse, for which the Reporting Person and the Reporting Person's spouse serve as trustees.